Eben Tessari is CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 44,452 shares of KNSA, which is worth approximately $1.64 Million. The most recent transaction as insider was on Sep 05, 2025, when has been sold 13,389 shares (Class A Ordinary Share) at a price of $35.66 per share, resulting in proceeds of $477,451. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.5K
38.57% 3M change
64.29% 12M change
Total Value Held $1.64 Million

Eben Tessari Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 05 2025
SELL
Open market or private sale
$477,451 $35.66 p/Share
13,389 Reduced 23.15%
44,452 Class A Ordinary Share
Sep 05 2025
BUY
Exercise of conversion of derivative security
$207,797 $15.52 p/Share
13,389 Added 18.8%
57,841 Class A Ordinary Share
Sep 04 2025
SELL
Open market or private sale
$3,028,825 $35.52 p/Share
85,271 Reduced 65.73%
44,452 Class A Ordinary Share
Sep 04 2025
BUY
Exercise of conversion of derivative security
$1,322,553 $15.51 p/Share
85,271 Added 39.66%
129,723 Class A Ordinary Share
Sep 03 2025
SELL
Open market or private sale
$535,730 $35.5 p/Share
15,091 Reduced 25.34%
44,452 Class A Ordinary Share
Sep 03 2025
BUY
Exercise of conversion of derivative security
$234,061 $15.51 p/Share
15,091 Added 20.22%
59,543 Class A Ordinary Share
Sep 02 2025
SELL
Payment of exercise price or tax liability
$32,566 $34.28 p/Share
950 Reduced 2.09%
44,452 Class A Ordinary Share
Sep 02 2025
BUY
Exercise of conversion of derivative security
-
1,964 Added 4.15%
45,402 Class A Ordinary Share
Sep 01 2025
SELL
Payment of exercise price or tax liability
$101,206 $33.49 p/Share
3,022 Reduced 6.5%
43,438 Class A Ordinary Share
Sep 01 2025
BUY
Exercise of conversion of derivative security
-
6,245 Added 11.85%
46,460 Class A Ordinary Share
Aug 18 2025
SELL
Open market or private sale
$552,582 $34.11 p/Share
16,200 Reduced 28.72%
40,215 Class A Ordinary Share
Aug 18 2025
BUY
Exercise of conversion of derivative security
$57,395 $8.83 p/Share
6,500 Added 10.33%
56,415 Class A Ordinary Share
Aug 05 2025
SELL
Open market or private sale
$4,650,499 $33.55 p/Share
138,614 Reduced 73.52%
49,915 Class A Ordinary Share
Aug 05 2025
BUY
Exercise of conversion of derivative security
$1,584,358 $11.43 p/Share
138,614 Added 42.37%
188,529 Class A Ordinary Share
Jul 15 2025
BUY
Grant, award, or other acquisition
$11,753 $15.63 p/Share
752 Added 1.48%
49,915 Class A Ordinary Share
Jul 14 2025
SELL
Open market or private sale
$542,808 $28.72 p/Share
18,900 Reduced 27.77%
49,163 Class A Ordinary Share
Jul 14 2025
BUY
Exercise of conversion of derivative security
$57,395 $8.83 p/Share
6,500 Added 8.72%
68,063 Class A Ordinary Share
Jun 16 2025
SELL
Open market or private sale
$489,244 $28.28 p/Share
17,300 Reduced 21.94%
61,563 Class A Ordinary Share
Jun 16 2025
BUY
Exercise of conversion of derivative security
$57,395 $8.83 p/Share
6,500 Added 7.61%
78,863 Class A Ordinary Share
Jun 11 2025
SELL
Open market or private sale
$1,374,231 $30.51 p/Share
45,042 Reduced 38.36%
72,363 Class A Ordinary Share
Jun 11 2025
BUY
Exercise of conversion of derivative security
$466,635 $10.36 p/Share
45,042 Added 27.73%
117,405 Class A Ordinary Share
Jun 10 2025
SELL
Open market or private sale
$472,312 $30.46 p/Share
15,506 Reduced 17.65%
72,363 Class A Ordinary Share
Jun 10 2025
BUY
Exercise of conversion of derivative security
$160,642 $10.36 p/Share
15,506 Added 15.0%
87,869 Class A Ordinary Share
Jun 09 2025
SELL
Open market or private sale
$313,491 $30.38 p/Share
10,319 Reduced 12.48%
72,363 Class A Ordinary Share
Jun 09 2025
BUY
Exercise of conversion of derivative security
$106,904 $10.36 p/Share
10,319 Added 11.1%
82,682 Class A Ordinary Share
ET

Eben Tessari

CHIEF OPERATING OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA